View ValuationNational Oxygen 将来の成長Future 基準チェック /06現在、 National Oxygenの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長18.3%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 26Full year 2026 earnings released: EPS: ₹3.64 (vs ₹13.89 loss in FY 2025)Full year 2026 results: EPS: ₹3.64 (up from ₹13.89 loss in FY 2025). Revenue: ₹237.2m (down 42% from FY 2025). Net income: ₹18.4m (up ₹88.4m from FY 2025). Profit margin: 7.7% (up from net loss in FY 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • May 19National Oxygen Limited to Report Q4, 2026 Results on May 25, 2026National Oxygen Limited announced that they will report Q4, 2026 results on May 25, 2026Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.98, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 7.7% over the past three years.Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹67.42, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.お知らせ • Mar 21National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement to issue 950,000 shares on March 20, 2026. The transaction will include participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by shareholders of company.Reported Earnings • Jan 31Third quarter 2026 earnings released: ₹3.08 loss per share (vs ₹3.92 loss in 3Q 2025)Third quarter 2026 results: ₹3.08 loss per share (improved from ₹3.92 loss in 3Q 2025). Revenue: ₹51.5m (down 52% from 3Q 2025). Net loss: ₹15.5m (loss narrowed 21% from 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Jan 27National Oxygen Limited to Report Q3, 2026 Results on Jan 30, 2026National Oxygen Limited announced that they will report Q3, 2026 results on Jan 30, 2026Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹93.46, the stock trades at a trailing P/E ratio of 78.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹28m). Market cap is less than US$10m (₹449.3m market cap, or US$4.99m). Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹334m revenue, or US$3.7m).Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹78.65, the stock trades at a trailing P/E ratio of 66x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.Valuation Update With 7 Day Price Move • Dec 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹95.00, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹13.96 (vs ₹2.35 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹13.96 (up from ₹2.35 loss in 2Q 2025). Revenue: ₹66.2m (down 38% from 2Q 2025). Net income: ₹70.4m (up ₹82.3m from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.お知らせ • Nov 07National Oxygen Limited to Report Q2, 2026 Results on Nov 12, 2025National Oxygen Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Aug 29National Oxygen Limited, Annual General Meeting, Sep 24, 2025National Oxygen Limited, Annual General Meeting, Sep 24, 2025, at 11:30 Indian Standard Time.New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹3.7m free cash flow). Negative equity (-₹80m). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (₹634.1m market cap, or US$7.27m). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Revenue is less than US$5m (₹376m revenue, or US$4.3m).Reported Earnings • Aug 08First quarter 2026 earnings released: ₹3.71 loss per share (vs ₹2.47 loss in 1Q 2025)First quarter 2026 results: ₹3.71 loss per share (further deteriorated from ₹2.47 loss in 1Q 2025). Revenue: ₹76.4m (down 28% from 1Q 2025). Net loss: ₹18.7m (loss widened 50% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.お知らせ • Aug 05National Oxygen Limited to Report Q1, 2026 Results on Aug 07, 2025National Oxygen Limited announced that they will report Q1, 2026 results on Aug 07, 2025Reported Earnings • May 31Full year 2025 earnings released: ₹13.90 loss per share (vs ₹6.41 loss in FY 2024)Full year 2025 results: ₹13.90 loss per share (further deteriorated from ₹6.41 loss in FY 2024). Revenue: ₹408.6m (down 9.7% from FY 2024). Net loss: ₹70.0m (loss widened 117% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.お知らせ • May 26National Oxygen Limited to Report Q4, 2025 Results on May 29, 2025National Oxygen Limited announced that they will report Q4, 2025 results on May 29, 2025Reported Earnings • Feb 08Third quarter 2025 earnings released: ₹3.92 loss per share (vs ₹2.52 loss in 3Q 2024)Third quarter 2025 results: ₹3.92 loss per share (further deteriorated from ₹2.52 loss in 3Q 2024). Revenue: ₹108.5m (down 4.0% from 3Q 2024). Net loss: ₹19.8m (loss widened 63% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.New Risk • Feb 03New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹435m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹34m). Earnings have declined by 15% per year over the past 5 years. Market cap is less than US$10m (₹607.9m market cap, or US$6.98m). Minor Risk Revenue is less than US$5m (₹435m revenue, or US$5.0m).お知らせ • Jan 29National Oxygen Limited to Report Q3, 2025 Results on Feb 07, 2025National Oxygen Limited announced that they will report Q3, 2025 results on Feb 07, 2025Reported Earnings • Nov 13Second quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.26 loss in 2Q 2024)Second quarter 2025 results: ₹2.35 loss per share (further deteriorated from ₹1.26 loss in 2Q 2024). Revenue: ₹106.9m (down 9.5% from 2Q 2024). Net loss: ₹11.9m (loss widened 97% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 151 percentage points per year, which is a significant difference in performance.お知らせ • Nov 09National Oxygen Limited to Report Q2, 2025 Results on Nov 11, 2024National Oxygen Limited announced that they will report Q2, 2025 results on Nov 11, 2024Reported Earnings • Aug 14First quarter 2025 earnings released: ₹2.47 loss per share (vs ₹1.21 loss in 1Q 2024)First quarter 2025 results: ₹2.47 loss per share (further deteriorated from ₹1.21 loss in 1Q 2024). Revenue: ₹106.3m (down 4.4% from 1Q 2024). Net loss: ₹12.5m (loss widened 115% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 143 percentage points per year, which is a significant difference in performance.お知らせ • Aug 13National Oxygen Limited, Annual General Meeting, Sep 16, 2024National Oxygen Limited, Annual General Meeting, Sep 16, 2024.お知らせ • Aug 02National Oxygen Limited to Report Q1, 2025 Results on Aug 13, 2024National Oxygen Limited announced that they will report Q1, 2025 results on Aug 13, 2024Reported Earnings • May 23Full year 2024 earnings released: ₹6.60 loss per share (vs ₹1.65 loss in FY 2023)Full year 2024 results: ₹6.60 loss per share (further deteriorated from ₹1.65 loss in FY 2023). Revenue: ₹457.6m (down 2.9% from FY 2023). Net loss: ₹32.3m (loss widened 309% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.New Risk • May 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹816.6m market cap, or US$9.80m). Minor Risk Shareholders have been diluted in the past year (5.0% increase in shares outstanding).お知らせ • May 15National Oxygen Limited to Report Q4, 2024 Results on May 22, 2024National Oxygen Limited announced that they will report Q4, 2024 results on May 22, 2024New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹673.8m market cap, or US$8.07m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).お知らせ • Feb 03National Oxygen Limited to Report Q3, 2024 Results on Feb 09, 2024National Oxygen Limited announced that they will report Q3, 2024 results on Feb 09, 2024お知らせ • Jan 22National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement of 240,114 common shares on January 20, 2024. The transaction included participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by the board of directors of the company.Reported Earnings • Nov 09Second quarter 2024 earnings released: ₹1.26 loss per share (vs ₹2.43 loss in 2Q 2023)Second quarter 2024 results: ₹1.26 loss per share (improved from ₹2.43 loss in 2Q 2023). Revenue: ₹119.3m (up 1.6% from 2Q 2023). Net loss: ₹6.03m (loss narrowed 48% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹9.3m). Market cap is less than US$10m (₹587.3m market cap, or US$7.07m). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).Reported Earnings • Aug 06Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹471.1m (down 6.9% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 04National Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023National Oxygen Limited announced that they will report Q1, 2024 results on Aug 11, 2023お知らせ • Aug 03National Oxygen Limited, Annual General Meeting, Aug 28, 2023National Oxygen Limited, Annual General Meeting, Aug 28, 2023, at 11:30 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon; to appoint a director in place of Ms. Sarita Saraf who retires from office by rotation and being eligible offers herself for reappointment; to reappoint Ms. Mona Milan Parekh as independent director of the company for a second term of five consecutive year to reappoint Mr. Rajesh Kumar Saraf as independent director of the company for a second term of five consecutive year; and to consider other matters.Reported Earnings • May 30Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹477.0m (down 6.1% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 48% per year.お知らせ • May 19National Oxygen Limited to Report Q4, 2023 Results on May 24, 2023National Oxygen Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 24, 2023Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Amit Agarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 06Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹1.44 profit in 3Q 2022)Third quarter 2023 results: ₹1.00 loss per share (down from ₹1.44 profit in 3Q 2022). Revenue: ₹119.2m (flat on 3Q 2022). Net loss: ₹4.83m (down 170% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth.お知らせ • Jan 26National Oxygen Limited to Report Q3, 2023 Results on Feb 03, 2023National Oxygen Limited announced that they will report Q3, 2023 results on Feb 03, 2023Reported Earnings • Nov 05Second quarter 2023 earnings released: ₹2.43 loss per share (vs ₹4.00 profit in 2Q 2022)Second quarter 2023 results: ₹2.43 loss per share (down from ₹4.00 profit in 2Q 2022). Revenue: ₹117.7m (down 11% from 2Q 2022). Net loss: ₹11.7m (down 161% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 27National Oxygen Limited to Report First Half, 2022 Results on Nov 04, 2022National Oxygen Limited announced that they will report first half, 2022 results on Nov 04, 2022Reported Earnings • Jul 26First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹8.40 in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (down from ₹8.40 in 1Q 2022). Revenue: ₹114.2m (down 21% from 1Q 2022). Net income: ₹170.0k (down 100% from 1Q 2022). Profit margin: 0.1% (down from 28% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 26National Oxygen Limited, Annual General Meeting, Aug 30, 2022National Oxygen Limited, Annual General Meeting, Aug 30, 2022. Agenda: To discuss the re-appointment of independent director for the second term of five years; to discuss the issue of equity shares on preferential basis to promoter group company alterations of memorandum of association; to discuss the related party transactions; to discuss the directors report and the audit report; and to discuss other matters.お知らせ • Jul 15National Oxygen Limited to Report Q1, 2023 Results on Jul 25, 2022National Oxygen Limited announced that they will report Q1, 2023 results at 12:15 PM, Indian Standard Time on Jul 25, 2022Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹114, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 182% over the past three years.Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹108, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 167% over the past three years.お知らせ • May 23National Oxygen Limited Appoints Sarita Saraff as Marketing HeadNational Oxygen Limited appointed Sarita Saraff as Marketing Head at the Board Meeting held on May 21, 2022.Reported Earnings • May 22Full year 2022 earnings released: EPS: ₹15.88 (vs ₹2.28 loss in FY 2021)Full year 2022 results: EPS: ₹15.88 (up from ₹2.28 loss in FY 2021). Revenue: ₹520.5m (up 30% from FY 2021). Net income: ₹76.3m (up ₹87.2m from FY 2021). Profit margin: 15% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.お知らせ • May 14National Oxygen Limited to Report Q4, 2022 Results on May 21, 2022National Oxygen Limited announced that they will report Q4, 2022 results on May 21, 2022Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹115, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 211% over the past three years.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 86% over the past three years.Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.44 (down from ₹2.94 in 3Q 2021). Revenue: ₹118.8m (down 5.8% from 3Q 2021). Net income: ₹6.93m (down 51% from 3Q 2021). Profit margin: 5.8% (down from 11% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹118, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 219% over the past three years.Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹128, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 226% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 74% over the past three years.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹65.10, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 243% over the past three years.Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹8.40 (vs ₹4.77 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹145.1m (up 120% from 1Q 2021). Net income: ₹40.3m (up ₹63.2m from 1Q 2021). Profit margin: 28% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 45% per year, which means it is well ahead of earnings.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹2.94 (vs ₹1.34 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹126.4m (up 15% from 3Q 2020). Net income: ₹14.1m (up ₹20.5m from 3Q 2020). Profit margin: 11% (up from net loss in 3Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 63% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • Feb 04National Oxygen Limited to Report Q3, 2021 Results on Feb 09, 2021National Oxygen Limited announced that they will report Q3, 2021 results on Feb 09, 2021Is New 90 Day High Low • Jan 28New 90-day high: ₹46.50The company is up 21% from its price of ₹38.35 on 26 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Dec 02New 90-day low: ₹36.00The company is down 9.0% from its price of ₹39.50 on 03 September 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Reported Earnings • Nov 12Second quarter 2021 earnings released: ₹2.53 loss per shareThe company reported a poor second quarter result with weaker earnings, revenues and control over expenses. Second quarter 2021 results: Revenue: ₹90.6m (down 22% from 2Q 2020). Net loss: ₹12.2m (down ₹13.3m from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Sep 18New 90-day high: ₹43.55The company is up 20% from its price of ₹36.15 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、National Oxygen は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:507813 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202623018-57-11N/A12/31/202527610N/AN/AN/A9/30/20253346-38-1N/A6/30/2025376-76N/AN/AN/A3/31/2025406-70-4-2N/A12/31/2024430-52N/AN/AN/A9/30/2024435-452657N/A6/30/2024447-39N/AN/AN/A3/31/2024453-32-2910N/A12/31/2023463-16N/AN/AN/A9/30/2023470-8-24-9N/A6/30/2023469-14N/AN/AN/A3/31/2023471-81422N/A12/31/2022473-6N/AN/AN/A9/30/202247253445N/A6/30/202247536N/AN/AN/A3/31/202250676106116N/A12/31/202151376N/AN/AN/A9/30/202152084108116N/A6/30/202148152N/AN/AN/A3/31/2021398-115765N/A12/31/2020386-25N/AN/AN/A9/30/2020371-463636N/A6/30/2020396-33N/AN/AN/A3/31/2020439-164348N/A12/31/2019450-8N/AN/AN/A9/30/20194624N/A77N/A6/30/20194646N/AN/AN/A3/31/201946236N/A78N/A12/31/201846735N/AN/AN/A9/30/201843927N/AN/AN/A6/30/201842518N/AN/AN/A3/31/2018414-19N/A85N/A12/31/2017404-17N/AN/AN/A9/30/2017376-46N/AN/AN/A6/30/2017378-43N/AN/AN/A3/31/2017361-54N/A49N/A12/31/2016363-50N/AN/AN/A9/30/2016348-56N/AN/AN/A6/30/2016343-55N/AN/AN/A3/31/2016332-57N/A15N/A12/31/2015297-78N/AN/AN/A9/30/2015292-84N/AN/AN/A6/30/2015282-95N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 507813の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 507813の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 507813の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 507813の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 507813の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 507813の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 06:50終値2026/06/12 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋National Oxygen Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 26Full year 2026 earnings released: EPS: ₹3.64 (vs ₹13.89 loss in FY 2025)Full year 2026 results: EPS: ₹3.64 (up from ₹13.89 loss in FY 2025). Revenue: ₹237.2m (down 42% from FY 2025). Net income: ₹18.4m (up ₹88.4m from FY 2025). Profit margin: 7.7% (up from net loss in FY 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • May 19National Oxygen Limited to Report Q4, 2026 Results on May 25, 2026National Oxygen Limited announced that they will report Q4, 2026 results on May 25, 2026
Valuation Update With 7 Day Price Move • May 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.98, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 7.7% over the past three years.
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹67.42, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 27% over the past three years.
お知らせ • Mar 21National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement to issue 950,000 shares on March 20, 2026. The transaction will include participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by shareholders of company.
Reported Earnings • Jan 31Third quarter 2026 earnings released: ₹3.08 loss per share (vs ₹3.92 loss in 3Q 2025)Third quarter 2026 results: ₹3.08 loss per share (improved from ₹3.92 loss in 3Q 2025). Revenue: ₹51.5m (down 52% from 3Q 2025). Net loss: ₹15.5m (loss narrowed 21% from 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 27National Oxygen Limited to Report Q3, 2026 Results on Jan 30, 2026National Oxygen Limited announced that they will report Q3, 2026 results on Jan 30, 2026
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹93.46, the stock trades at a trailing P/E ratio of 78.5x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 39% over the past three years.
New Risk • Jan 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-₹28m). Market cap is less than US$10m (₹449.3m market cap, or US$4.99m). Minor Risks Share price has been volatile over the past 3 months (7.0% average weekly change). Large one-off items impacting financial results. Revenue is less than US$5m (₹334m revenue, or US$3.7m).
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹78.65, the stock trades at a trailing P/E ratio of 66x. Average trailing P/E is 23x in the Chemicals industry in India. Total loss to shareholders of 54% over the past three years.
Valuation Update With 7 Day Price Move • Dec 08Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹95.00, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total loss to shareholders of 26% over the past three years.
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: ₹13.96 (vs ₹2.35 loss in 2Q 2025)Second quarter 2026 results: EPS: ₹13.96 (up from ₹2.35 loss in 2Q 2025). Revenue: ₹66.2m (down 38% from 2Q 2025). Net income: ₹70.4m (up ₹82.3m from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
お知らせ • Nov 07National Oxygen Limited to Report Q2, 2026 Results on Nov 12, 2025National Oxygen Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Aug 29National Oxygen Limited, Annual General Meeting, Sep 24, 2025National Oxygen Limited, Annual General Meeting, Sep 24, 2025, at 11:30 Indian Standard Time.
New Risk • Aug 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-₹3.7m free cash flow). Negative equity (-₹80m). Earnings have declined by 40% per year over the past 5 years. Market cap is less than US$10m (₹634.1m market cap, or US$7.27m). Minor Risks Share price has been volatile over the past 3 months (6.8% average weekly change). Revenue is less than US$5m (₹376m revenue, or US$4.3m).
Reported Earnings • Aug 08First quarter 2026 earnings released: ₹3.71 loss per share (vs ₹2.47 loss in 1Q 2025)First quarter 2026 results: ₹3.71 loss per share (further deteriorated from ₹2.47 loss in 1Q 2025). Revenue: ₹76.4m (down 28% from 1Q 2025). Net loss: ₹18.7m (loss widened 50% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 05National Oxygen Limited to Report Q1, 2026 Results on Aug 07, 2025National Oxygen Limited announced that they will report Q1, 2026 results on Aug 07, 2025
Reported Earnings • May 31Full year 2025 earnings released: ₹13.90 loss per share (vs ₹6.41 loss in FY 2024)Full year 2025 results: ₹13.90 loss per share (further deteriorated from ₹6.41 loss in FY 2024). Revenue: ₹408.6m (down 9.7% from FY 2024). Net loss: ₹70.0m (loss widened 117% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.
お知らせ • May 26National Oxygen Limited to Report Q4, 2025 Results on May 29, 2025National Oxygen Limited announced that they will report Q4, 2025 results on May 29, 2025
Reported Earnings • Feb 08Third quarter 2025 earnings released: ₹3.92 loss per share (vs ₹2.52 loss in 3Q 2024)Third quarter 2025 results: ₹3.92 loss per share (further deteriorated from ₹2.52 loss in 3Q 2024). Revenue: ₹108.5m (down 4.0% from 3Q 2024). Net loss: ₹19.8m (loss widened 63% from 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.
New Risk • Feb 03New minor risk - Revenue sizeThe company makes less than US$5m in revenue. Total revenue: ₹435m (US$5.0m) This is considered a minor risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹34m). Earnings have declined by 15% per year over the past 5 years. Market cap is less than US$10m (₹607.9m market cap, or US$6.98m). Minor Risk Revenue is less than US$5m (₹435m revenue, or US$5.0m).
お知らせ • Jan 29National Oxygen Limited to Report Q3, 2025 Results on Feb 07, 2025National Oxygen Limited announced that they will report Q3, 2025 results on Feb 07, 2025
Reported Earnings • Nov 13Second quarter 2025 earnings released: ₹2.35 loss per share (vs ₹1.26 loss in 2Q 2024)Second quarter 2025 results: ₹2.35 loss per share (further deteriorated from ₹1.26 loss in 2Q 2024). Revenue: ₹106.9m (down 9.5% from 2Q 2024). Net loss: ₹11.9m (loss widened 97% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 151 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 09National Oxygen Limited to Report Q2, 2025 Results on Nov 11, 2024National Oxygen Limited announced that they will report Q2, 2025 results on Nov 11, 2024
Reported Earnings • Aug 14First quarter 2025 earnings released: ₹2.47 loss per share (vs ₹1.21 loss in 1Q 2024)First quarter 2025 results: ₹2.47 loss per share (further deteriorated from ₹1.21 loss in 1Q 2024). Revenue: ₹106.3m (down 4.4% from 1Q 2024). Net loss: ₹12.5m (loss widened 115% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 143 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 13National Oxygen Limited, Annual General Meeting, Sep 16, 2024National Oxygen Limited, Annual General Meeting, Sep 16, 2024.
お知らせ • Aug 02National Oxygen Limited to Report Q1, 2025 Results on Aug 13, 2024National Oxygen Limited announced that they will report Q1, 2025 results on Aug 13, 2024
Reported Earnings • May 23Full year 2024 earnings released: ₹6.60 loss per share (vs ₹1.65 loss in FY 2023)Full year 2024 results: ₹6.60 loss per share (further deteriorated from ₹1.65 loss in FY 2023). Revenue: ₹457.6m (down 2.9% from FY 2023). Net loss: ₹32.3m (loss widened 309% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 122 percentage points per year, which is a significant difference in performance.
New Risk • May 21New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹816.6m market cap, or US$9.80m). Minor Risk Shareholders have been diluted in the past year (5.0% increase in shares outstanding).
お知らせ • May 15National Oxygen Limited to Report Q4, 2024 Results on May 22, 2024National Oxygen Limited announced that they will report Q4, 2024 results on May 22, 2024
New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹21m). Earnings have declined by 1.5% per year over the past 5 years. Market cap is less than US$10m (₹673.8m market cap, or US$8.07m). Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).
お知らせ • Feb 03National Oxygen Limited to Report Q3, 2024 Results on Feb 09, 2024National Oxygen Limited announced that they will report Q3, 2024 results on Feb 09, 2024
お知らせ • Jan 22National Oxygen Limited announced that it expects to receive funding from Saraf Housing Development Private LimitedNational Oxygen Limited announced a private placement of 240,114 common shares on January 20, 2024. The transaction included participation from new investor Saraf Housing Development Private Limited. The transaction has been approved by the board of directors of the company.
Reported Earnings • Nov 09Second quarter 2024 earnings released: ₹1.26 loss per share (vs ₹2.43 loss in 2Q 2023)Second quarter 2024 results: ₹1.26 loss per share (improved from ₹2.43 loss in 2Q 2023). Revenue: ₹119.3m (up 1.6% from 2Q 2023). Net loss: ₹6.03m (loss narrowed 48% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.
New Risk • Aug 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-₹9.3m). Market cap is less than US$10m (₹587.3m market cap, or US$7.07m). Minor Risk Share price has been volatile over the past 3 months (8.2% average weekly change).
Reported Earnings • Aug 06Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹471.1m (down 6.9% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 04National Oxygen Limited to Report Q1, 2024 Results on Aug 11, 2023National Oxygen Limited announced that they will report Q1, 2024 results on Aug 11, 2023
お知らせ • Aug 03National Oxygen Limited, Annual General Meeting, Aug 28, 2023National Oxygen Limited, Annual General Meeting, Aug 28, 2023, at 11:30 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023 together with the Reports of the Board of Directors and the Auditors thereon; to appoint a director in place of Ms. Sarita Saraf who retires from office by rotation and being eligible offers herself for reappointment; to reappoint Ms. Mona Milan Parekh as independent director of the company for a second term of five consecutive year to reappoint Mr. Rajesh Kumar Saraf as independent director of the company for a second term of five consecutive year; and to consider other matters.
Reported Earnings • May 30Full year 2023 earnings released: ₹1.65 loss per share (vs ₹15.88 profit in FY 2022)Full year 2023 results: ₹1.65 loss per share (down from ₹15.88 profit in FY 2022). Revenue: ₹477.0m (down 6.1% from FY 2022). Net loss: ₹7.91m (down 110% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 48% per year.
お知らせ • May 19National Oxygen Limited to Report Q4, 2023 Results on May 24, 2023National Oxygen Limited announced that they will report Q4, 2023 results at 3:30 PM, Indian Standard Time on May 24, 2023
Board Change • Apr 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Director Amit Agarwal was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 06Third quarter 2023 earnings released: ₹1.00 loss per share (vs ₹1.44 profit in 3Q 2022)Third quarter 2023 results: ₹1.00 loss per share (down from ₹1.44 profit in 3Q 2022). Revenue: ₹119.2m (flat on 3Q 2022). Net loss: ₹4.83m (down 170% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 52% per year, which means it is significantly lagging earnings growth.
お知らせ • Jan 26National Oxygen Limited to Report Q3, 2023 Results on Feb 03, 2023National Oxygen Limited announced that they will report Q3, 2023 results on Feb 03, 2023
Reported Earnings • Nov 05Second quarter 2023 earnings released: ₹2.43 loss per share (vs ₹4.00 profit in 2Q 2022)Second quarter 2023 results: ₹2.43 loss per share (down from ₹4.00 profit in 2Q 2022). Revenue: ₹117.7m (down 11% from 2Q 2022). Net loss: ₹11.7m (down 161% from profit in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 77% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 27National Oxygen Limited to Report First Half, 2022 Results on Nov 04, 2022National Oxygen Limited announced that they will report first half, 2022 results on Nov 04, 2022
Reported Earnings • Jul 26First quarter 2023 earnings released: EPS: ₹0.04 (vs ₹8.40 in 1Q 2022)First quarter 2023 results: EPS: ₹0.04 (down from ₹8.40 in 1Q 2022). Revenue: ₹114.2m (down 21% from 1Q 2022). Net income: ₹170.0k (down 100% from 1Q 2022). Profit margin: 0.1% (down from 28% in 1Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 49% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 26National Oxygen Limited, Annual General Meeting, Aug 30, 2022National Oxygen Limited, Annual General Meeting, Aug 30, 2022. Agenda: To discuss the re-appointment of independent director for the second term of five years; to discuss the issue of equity shares on preferential basis to promoter group company alterations of memorandum of association; to discuss the related party transactions; to discuss the directors report and the audit report; and to discuss other matters.
お知らせ • Jul 15National Oxygen Limited to Report Q1, 2023 Results on Jul 25, 2022National Oxygen Limited announced that they will report Q1, 2023 results at 12:15 PM, Indian Standard Time on Jul 25, 2022
Valuation Update With 7 Day Price Move • Jul 11Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹114, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 182% over the past three years.
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹108, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 167% over the past three years.
お知らせ • May 23National Oxygen Limited Appoints Sarita Saraff as Marketing HeadNational Oxygen Limited appointed Sarita Saraff as Marketing Head at the Board Meeting held on May 21, 2022.
Reported Earnings • May 22Full year 2022 earnings released: EPS: ₹15.88 (vs ₹2.28 loss in FY 2021)Full year 2022 results: EPS: ₹15.88 (up from ₹2.28 loss in FY 2021). Revenue: ₹520.5m (up 30% from FY 2021). Net income: ₹76.3m (up ₹87.2m from FY 2021). Profit margin: 15% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth.
お知らせ • May 14National Oxygen Limited to Report Q4, 2022 Results on May 21, 2022National Oxygen Limited announced that they will report Q4, 2022 results on May 21, 2022
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹115, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 211% over the past three years.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₹100, the stock trades at a trailing P/E ratio of 6.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 160% over the past three years.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 86% over the past three years.
Reported Earnings • Feb 13Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.44 (down from ₹2.94 in 3Q 2021). Revenue: ₹118.8m (down 5.8% from 3Q 2021). Net income: ₹6.93m (down 51% from 3Q 2021). Profit margin: 5.8% (down from 11% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to ₹118, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 219% over the past three years.
Valuation Update With 7 Day Price Move • Dec 28Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹128, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 226% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₹75.80, the stock trades at a trailing P/E ratio of 4.4x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 74% over the past three years.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹65.10, the stock trades at a trailing P/E ratio of 6x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 243% over the past three years.
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS ₹8.40 (vs ₹4.77 loss in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹145.1m (up 120% from 1Q 2021). Net income: ₹40.3m (up ₹63.2m from 1Q 2021). Profit margin: 28% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 45% per year, which means it is well ahead of earnings.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹2.94 (vs ₹1.34 loss in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹126.4m (up 15% from 3Q 2020). Net income: ₹14.1m (up ₹20.5m from 3Q 2020). Profit margin: 11% (up from net loss in 3Q 2020). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 63% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 04National Oxygen Limited to Report Q3, 2021 Results on Feb 09, 2021National Oxygen Limited announced that they will report Q3, 2021 results on Feb 09, 2021
Is New 90 Day High Low • Jan 28New 90-day high: ₹46.50The company is up 21% from its price of ₹38.35 on 26 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Dec 02New 90-day low: ₹36.00The company is down 9.0% from its price of ₹39.50 on 03 September 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Reported Earnings • Nov 12Second quarter 2021 earnings released: ₹2.53 loss per shareThe company reported a poor second quarter result with weaker earnings, revenues and control over expenses. Second quarter 2021 results: Revenue: ₹90.6m (down 22% from 2Q 2020). Net loss: ₹12.2m (down ₹13.3m from profit in 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Sep 18New 90-day high: ₹43.55The company is up 20% from its price of ₹36.15 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 21% over the same period.